Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (ABVX) FCF Margin (2024 - 2025)

Historic FCF Margin for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to 90.85%.

  • Abivax's FCF Margin rose 2671000.0% to 90.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 210.49%, marking a year-over-year increase of 5725700.0%. This contributed to the annual value of 1242.77% for FY2024, which is 8648900.0% up from last year.
  • According to the latest figures from Q3 2025, Abivax's FCF Margin is 90.85%, which was up 2671000.0% from 635.05% recorded in Q2 2025.
  • Abivax's 5-year FCF Margin high stood at 115.18% for Q4 2024, and its period low was 641.71% during Q1 2024.